MediWound Ltd (NAS:MDWD)
$ 16.65 -0.26 (-1.54%) Market Cap: 179.59 Mil Enterprise Value: 160.58 Mil PE Ratio: 0 PB Ratio: 8.67 GF Score: 56/100

Q2 2020 Mediwound Ltd Earnings Call Transcript

Aug 06, 2020 / 12:30PM GMT
Release Date Price: $28.98 (+0.49%)
Operator

Good morning, ladies and gentlemen, and welcome to the Q2 MediWound 2020 conference call. (Operator Instructions) As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Mr. Jeremy Feffer. Please go ahead, sir.

Jeremy Feffer
LifeSci Advisors, LLC - MD

Thank you, Tiffany, and good morning, everyone. Earlier today, MediWound issued a press release announcing financial results and provided a business update for the second quarter of 2020. You may access that release on the company's website under the Investors tab.

With us today are Sharon Malka, Chief Executive Officer; and Boaz Gur-Lavie, Chief Financial Officer. Following management's prepared remarks, we will open the call for Q&A.

Before we begin, I would like to remind everyone that statements made during this call including the Q&A session relating to MediWound's expected future performance, future business prospects or future events or plans are forward-looking statements as defined under the Private Securities Litigation

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot